Clinical Trial Update: Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to oxytocin plus misoprostol for reducing blood loss during cesarean section has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss During Cesarean Section
• Intrapartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)
• MISOPROSTOL (Misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Blood Loss, Surgical, Intrapartum Hemorrhage | Phase 4 | Status: COMPLETED